Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 1
2006 1
2007 1
2008 1
2010 1
2012 1
2013 5
2014 4
2015 3
2016 3
2017 4
2018 3
2019 3
2020 3
2021 3
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group. Dick AD, et al. Ophthalmology. 2018 May;125(5):757-773. doi: 10.1016/j.ophtha.2017.11.017. Epub 2018 Jan 6. Ophthalmology. 2018. PMID: 29310963 Free article.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Behçet's syndrome: facts and controversies.
Mat C, Yurdakul S, Sevim A, Özyazgan Y, Tüzün Y. Mat C, et al. Among authors: ozyazgan y. Clin Dermatol. 2013 Jul-Aug;31(4):352-361. doi: 10.1016/j.clindermatol.2013.01.002. Clin Dermatol. 2013. PMID: 23806152 Review.
Pediatric Uveitis in Turkey: The National Registry Report II.
Yalçındağ FN, Özdal P, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I; BUST Study Group. Yalçındağ FN, et al. Among authors: ozyazgan y. Ocul Immunol Inflamm. 2023 Dec;31(10):1971-1977. doi: 10.1080/09273948.2022.2110900. Epub 2022 Sep 9. Ocul Immunol Inflamm. 2023. PMID: 36083691
An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults.
Tugal-Tutkun I, Onal S, Stanford M, Akman M, Twisk JWR, Boers M, Oray M, Özdal P, Kadayifcilar S, Amer R, Rathinam SR, Vedhanayaki R, Khairallah M, Akova Y, Yalcindag F, Kardes E, Basarir B, Altan Ç, Özyazgan Y, Gül A. Tugal-Tutkun I, et al. Among authors: ozyazgan y. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1154-1163. doi: 10.1080/09273948.2020.1736310. Epub 2020 Apr 14. Ocul Immunol Inflamm. 2021. PMID: 32286112
Emergence of new manifestations during infliximab treatment in Behçet's syndrome.
Tukek NB, Esatoglu SN, Hatemi G, Calıskan EB, Ozyazgan Y, Ucar D, Ozguler Y, Seyahi E, Melikoglu M, Uygunoglu U, Siva A, Kutlubay Z, Hatemi İ, Celik AF, Ugurlu S, Fresko I, Yurdakul S, Yazici H, Hamuryudan V. Tukek NB, et al. Among authors: ozyazgan y. Rheumatology (Oxford). 2022 Aug 30;61(9):3746-3753. doi: 10.1093/rheumatology/keab944. Rheumatology (Oxford). 2022. PMID: 34958357
Biosimilar infliximab for Behçet's syndrome: a case series.
Dincses E, Esatoglu SN, Ozguler Y, Uygunoglu U, Hamuryudan V, Seyahi E, Melikoglu M, Fresko I, Ucar D, Ozyazgan Y, Kutlubay Z, Mat MC, Yurdakul S, Siva A, Hatemi G. Dincses E, et al. Among authors: ozyazgan y. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):111-115. Epub 2019 Dec 9. Clin Exp Rheumatol. 2019. PMID: 31856937 Free article.
36 results